The Missing “lnc” between Genetics and Cardiac Disease
Cardiovascular disease (CVD) is one of the biggest threats to public health worldwide. Identifying key genetic contributors to CVD enables clinicians to assess the most effective treatment course and prognosis, as well as potentially inform family members. This often involves either whole exome sequ...
Main Authors: | Maral Azodi, Rick Kamps, Stephane Heymans, Emma Louise Robinson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Non-Coding RNA |
Subjects: | |
Online Access: | https://www.mdpi.com/2311-553X/6/1/3 |
Similar Items
-
Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant
by: Alessandro Borghesi, et al.
Published: (2017-11-01) -
Genetic Investigation of Inverse Psoriasis
by: Anikó Göblös, et al.
Published: (2021-07-01) -
Editorial: Advanced Interpretable Machine Learning Methods for Clinical NGS Big Data of Complex Hereditary Diseases
by: Yudong Cai, et al.
Published: (2020-10-01) -
Rare Genetic Variants in Jewish Patients Suffering from Age-Related Macular Degeneration
by: Nadav Shoshany, et al.
Published: (2019-10-01) -
Pathogenic variants identified by whole-exome sequencing in 43 patients with epilepsy
by: Linlin Zhang, et al.
Published: (2020-12-01)